The significance of strong histone deacetylase 1 expression in the progression of prostate cancer

Yoohyun Song, masaki shiota, Sadafumi Tamiya, Kentaro Kuroiwa, Seiji Naito, Masazumi Tsuneyoshi

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Aims: Histone deacetylases (HDACs) play important roles in many types of cancer. Recently, it has been reported that HDAC1 expression in prostate cancer is significantly higher than in benign prostate cell lines and tissues. The expression of HDAC1 in association with the clinicopathological data was investigated to define its functional and pathological roles in prostate cancer. Methods and results: HDAC1 expression was examined immunohistochemically in 148 patients with prostate cancer. Strong expression of HDAC1 in benign prostate glands, high-grade prostatic intraepithelial neoplasia (PIN) and prostate cancer was observed in 17/148 (11%), 19/71 (27%) and 69/148 (47%) patients. Strong HDAC1 expression was correlated with high Gleason score (P=0.025) and high pT stage (P=0.012). Patients with strong HDAC1 expression had higher biochemical recurrence rates (P=0.0010). Furthermore, strong HDAC1 expression had a significant impact on patient biochemical recurrence rates in multivariate analysis (P=0.004). Conclusions: These results indicate that overexpression of HDAC1 contributes to progression and poor prognosis in prostate cancer. The findings may play an important role in the emergence of effective new approaches for therapy and prognostic markers of prostate cancer.

Original languageEnglish
Pages (from-to)773-780
Number of pages8
JournalHistopathology
Volume58
Issue number5
DOIs
Publication statusPublished - Apr 1 2011

Fingerprint

Histone Deacetylase 1
Prostatic Neoplasms
Prostate
Prostatic Intraepithelial Neoplasia
Recurrence
Histone Deacetylases
Neoplasm Grading
Multivariate Analysis
Cell Line

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Histology

Cite this

The significance of strong histone deacetylase 1 expression in the progression of prostate cancer. / Song, Yoohyun; shiota, masaki; Tamiya, Sadafumi; Kuroiwa, Kentaro; Naito, Seiji; Tsuneyoshi, Masazumi.

In: Histopathology, Vol. 58, No. 5, 01.04.2011, p. 773-780.

Research output: Contribution to journalArticle

Song, Yoohyun ; shiota, masaki ; Tamiya, Sadafumi ; Kuroiwa, Kentaro ; Naito, Seiji ; Tsuneyoshi, Masazumi. / The significance of strong histone deacetylase 1 expression in the progression of prostate cancer. In: Histopathology. 2011 ; Vol. 58, No. 5. pp. 773-780.
@article{aace288677204871a6453293c877d944,
title = "The significance of strong histone deacetylase 1 expression in the progression of prostate cancer",
abstract = "Aims: Histone deacetylases (HDACs) play important roles in many types of cancer. Recently, it has been reported that HDAC1 expression in prostate cancer is significantly higher than in benign prostate cell lines and tissues. The expression of HDAC1 in association with the clinicopathological data was investigated to define its functional and pathological roles in prostate cancer. Methods and results: HDAC1 expression was examined immunohistochemically in 148 patients with prostate cancer. Strong expression of HDAC1 in benign prostate glands, high-grade prostatic intraepithelial neoplasia (PIN) and prostate cancer was observed in 17/148 (11{\%}), 19/71 (27{\%}) and 69/148 (47{\%}) patients. Strong HDAC1 expression was correlated with high Gleason score (P=0.025) and high pT stage (P=0.012). Patients with strong HDAC1 expression had higher biochemical recurrence rates (P=0.0010). Furthermore, strong HDAC1 expression had a significant impact on patient biochemical recurrence rates in multivariate analysis (P=0.004). Conclusions: These results indicate that overexpression of HDAC1 contributes to progression and poor prognosis in prostate cancer. The findings may play an important role in the emergence of effective new approaches for therapy and prognostic markers of prostate cancer.",
author = "Yoohyun Song and masaki shiota and Sadafumi Tamiya and Kentaro Kuroiwa and Seiji Naito and Masazumi Tsuneyoshi",
year = "2011",
month = "4",
day = "1",
doi = "10.1111/j.1365-2559.2011.03797.x",
language = "English",
volume = "58",
pages = "773--780",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - The significance of strong histone deacetylase 1 expression in the progression of prostate cancer

AU - Song, Yoohyun

AU - shiota, masaki

AU - Tamiya, Sadafumi

AU - Kuroiwa, Kentaro

AU - Naito, Seiji

AU - Tsuneyoshi, Masazumi

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Aims: Histone deacetylases (HDACs) play important roles in many types of cancer. Recently, it has been reported that HDAC1 expression in prostate cancer is significantly higher than in benign prostate cell lines and tissues. The expression of HDAC1 in association with the clinicopathological data was investigated to define its functional and pathological roles in prostate cancer. Methods and results: HDAC1 expression was examined immunohistochemically in 148 patients with prostate cancer. Strong expression of HDAC1 in benign prostate glands, high-grade prostatic intraepithelial neoplasia (PIN) and prostate cancer was observed in 17/148 (11%), 19/71 (27%) and 69/148 (47%) patients. Strong HDAC1 expression was correlated with high Gleason score (P=0.025) and high pT stage (P=0.012). Patients with strong HDAC1 expression had higher biochemical recurrence rates (P=0.0010). Furthermore, strong HDAC1 expression had a significant impact on patient biochemical recurrence rates in multivariate analysis (P=0.004). Conclusions: These results indicate that overexpression of HDAC1 contributes to progression and poor prognosis in prostate cancer. The findings may play an important role in the emergence of effective new approaches for therapy and prognostic markers of prostate cancer.

AB - Aims: Histone deacetylases (HDACs) play important roles in many types of cancer. Recently, it has been reported that HDAC1 expression in prostate cancer is significantly higher than in benign prostate cell lines and tissues. The expression of HDAC1 in association with the clinicopathological data was investigated to define its functional and pathological roles in prostate cancer. Methods and results: HDAC1 expression was examined immunohistochemically in 148 patients with prostate cancer. Strong expression of HDAC1 in benign prostate glands, high-grade prostatic intraepithelial neoplasia (PIN) and prostate cancer was observed in 17/148 (11%), 19/71 (27%) and 69/148 (47%) patients. Strong HDAC1 expression was correlated with high Gleason score (P=0.025) and high pT stage (P=0.012). Patients with strong HDAC1 expression had higher biochemical recurrence rates (P=0.0010). Furthermore, strong HDAC1 expression had a significant impact on patient biochemical recurrence rates in multivariate analysis (P=0.004). Conclusions: These results indicate that overexpression of HDAC1 contributes to progression and poor prognosis in prostate cancer. The findings may play an important role in the emergence of effective new approaches for therapy and prognostic markers of prostate cancer.

UR - http://www.scopus.com/inward/record.url?scp=79954591057&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954591057&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2559.2011.03797.x

DO - 10.1111/j.1365-2559.2011.03797.x

M3 - Article

C2 - 21438903

AN - SCOPUS:79954591057

VL - 58

SP - 773

EP - 780

JO - Histopathology

JF - Histopathology

SN - 0309-0167

IS - 5

ER -